TP53 and prostate carcinoma: Notably, this cell growth advantage conferred by the p53 loss-of-function under the standard, no-castration culture condition was not unique to the LNCaP cell line, as it was also observed in another TP53-wildtype prostate cancer cell line, MDA PCa 2b (Fig. 3B).